February 18, 2021 07:27 AM EST

Covid-19 roundup: South African variant trips up Pfizer/BioNTech, Moderna vaccines while EU seeks anti-variant contract clauses — report

Max Gelman

Senior Editor

Amber Tong

As questions continue to swirl about the effectiveness of current vaccines against new variants of the coronavirus, a pair of letters to the editor confirm …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: South African variant trips up Pfizer/BioNTech, Moderna vaccines while EU seeks anti-variant contract clauses — report

Max Gelman

Senior Editor

Amber Tong

Sign up to read this article for free.

Viking CEO on ‘shocking’ market reaction to oral obesity data, preparing for Phase 3

Beam discloses first clinical data on base-edited sickle cell therapy, one patient death

Vertex makes money from sickle cell therapy Casgevy

Sanofi reveals positive data for BTK inhibitor from $3.7B Principia takeover

Sana narrows focus again to zero in on diabetes and autoimmune disease

Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks

Covid-19 roundup: South African vari­ant trips up Pfiz­er/BioN­Tech, Mod­er­na vac­cines while EU seeks an­ti-vari­ant con­tract claus­es — re­port

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: South African variant trips up Pfizer/BioNTech, Moderna vaccines while EU seeks anti-variant contract clauses — report